Structured evidence table for Almond Ldl Cholesterol Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Almond Ldl Cholesterol Randomized Trial | This persistent inflammatory response is a key biological mechanism linking obesity to increased risk of insulin resistance, type 2 diabetes, and cardiovascular complications [,,,]. | 2 | Adepoju Ayodeji (2026) | Almond Consumption Improves Inflammatory Profiles Independent of Weight Change: A 6-Week Randomized Controlled Trial in Adults with Obesity |
| Almond Ldl Cholesterol Randomized Trial | Large epidemiological studies, including the Nurses’ Health Study and the ATTICA study, report that higher adherence to a MED-style dietary pattern is associated with lower concentrations of pro-inflammatory cytokines and immune cell counts [,]. | 2 | Adepoju Ayodeji (2026) | Almond Consumption Improves Inflammatory Profiles Independent of Weight Change: A 6-Week Randomized Controlled Trial in Adults with Obesity |
| Almond Ldl Cholesterol Randomized Trial | 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 Nuts are a core component of high-quality dietary patterns [] and may contribute substantially to the anti-inflammatory effects associated with these dietary patterns. | 2 | Adepoju Ayodeji (2026) | Almond Consumption Improves Inflammatory Profiles Independent of Weight Change: A 6-Week Randomized Controlled Trial in Adults with Obesity |
| Almond Ldl Cholesterol Randomized Trial | 1 2 1 2 3 4 5 6 7 Obesity is a state of chronic low-grade systemic inflammation, characterized by elevated circulating concentrations of pro-inflammatory cytokines and measurable shifts in innate immune cell populations [,]. | 2 | Adepoju Ayodeji (2026) | Almond Consumption Improves Inflammatory Profiles Independent of Weight Change: A 6-Week Randomized Controlled Trial in Adults with Obesity |
| Almond Ldl Cholesterol Randomized Trial | The orientation scale of the MMSE (p=0.024), MOCA (p=0.001), memory scale of MOCA (p=0.005), FAST (p=0.032), and PSQI (p Conclusion Almond is a probable safe intervention for memory and sleep enhancement in AD patients. | 2 | Mohajeri M (2026) | Almond for mild to moderate Alzheimer's disease: A randomized clinical trial. |
| Almond Ldl Cholesterol Randomized Trial | Objective Almonds are frequently advised as brain tonic and memory enhancers in Persian medicine. | 2 | Mohajeri M (2026) | Almond for mild to moderate Alzheimer's disease: A randomized clinical trial. |
| Almond Ldl Cholesterol Randomized Trial | This study was designed to assess the effects of almond ( Prunus dulcis ) on memory and cognitive functions in patients with Alzheimer's disease (AD). | 2 | Mohajeri M (2026) | Almond for mild to moderate Alzheimer's disease: A randomized clinical trial. |
Source documents